Erratum: Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes (Diabetologia DOI: 10.1007/s00125-010-1994-3);Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor proNGF expression in a rat model of diabetes

Diabetologia

Volumn 54, Issue 3, 2011, Pages 669-680

  Al Gayyar, M M H ^a,c,d   Matragoon, S ^a,c   Pillai, B A ^a,c   Ali, T K ^a,c,e   Abdelsaid, M A ^a,c   El Remessy, A B ^a,b,c  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MANSOURA UNIVERSITY   (Egypt)

^e Medical Center of Little Rock   (United States)

Author keywords

Diabetes; Epicatechin; Neuroprotection; Peroxynitrite; proNGF

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 NITROTYROSINE; EPICATECHIN; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN RECEPTOR P75; PEROXYNITRITE; PRO NERVE GROWTH FACTOR; PRO NERVE GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE A; SMALL INTERFERING RNA; STREPTOZOCIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG SAFETY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE SILENCING; GLIA CELL; INHIBITION KINETICS; MALE; MUELLER CELL; NERVE DEGENERATION; NICK END LABELING; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR UPREGULATION; RETINA GANGLION CELL; RETINA NERVE CELL; RNA INTERFERENCE; SLOT BLOT HYBRIDIZATION; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

EID: 79953764493     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-2035-y     Document Type: Erratum

References (50)

1. American Diabetes Association (2007) Diabetes Statistics. Available from www.diabetes.org/diabetes-basics/diabetes-statistics/?utm-source= WWW&utm-medium=DropDownDB&utm-content=Statistics&utm-campaign=CON, accessed November 2010
2. Ali TK, El-Remessy AB (2009) Diabetic retinopathy: current management and experimental therapeutic targets. Pharmacotherapy 29:182-192
3. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Investig 102:783-791 (Pubitemid 28399611)
4. Barber AJ, Antonetti DA, Kern TS et al (2005) The Ins2Akita mouse as a model of early retinal complications in diabetes. Investig Ophthalmol Vis Sci 46:2210-2218
5. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Investig Ophthalmol Vis Sci 45:3330-3336 (Pubitemid 39121873)
6. El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI (2006) Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol 168:235-244 (Pubitemid 43062576)
7. Ali TK, Matragoon S, Pillai BA, Liou GI, El-Remessy AB (2008) Peroxynitrite mediates retinal neurodegeneration by inhibiting NGF survival signal in experimental and human diabetes. J Diab 57:889-898
8. Azar ST, Major SC, Safieh-Garabedian B (1999) Altered plasma levels of nerve growth factor and transforming growth factor-beta2 in type-1 diabetes mellitus. Brain Behav Immun 13:361-366 (Pubitemid 30011993)
9. Park KS, Kim SS, Kim JC et al (2008) Serum and tear levels of nerve growth factor in diabetic retinopathy patients. Am J Ophthalmol 145:432-437 (Pubitemid 351240891)
10. Ali TK, Al-Gayyar MMH, Matragoon S et al. (2010) Diabetes-induced peroxynitrite impairs the balance of ProNGF/NGF and causes neurovascular injury. Diabetologia doi:10.1007/s00125-010-1935-1
11. Lee R, Kermani P, Teng KK, Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science New York, NY 294:1945-1948 (Pubitemid 33101595)
12. Hempstead BL (2009) Commentary: Regulating proNGF action: multiple targets for therapeutic intervention. Neurotox Res 16:255-260
13. Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383:716-719 (Pubitemid 26360647)
14. von Bartheld CS (1998) Neurotrophins in the developing and regenerating visual system. Histol Histopathol 13:437-459
15. Fahnestock M, Yu G, Michalski B et al (2004) The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor. J Neurochem 89:581-592 (Pubitemid 38534144)
16. Masoudi R, Ioannou MS, Coughlin MD et al (2009) Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors. J Biol Chem 284:18424-18433
17. El-Remessy AB, Bartoli M, Platt DH, Fulton D, Caldwell RB (2005) Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 118:243-252 (Pubitemid 40277119)
18. El-Remessy AB, Behzadian MA, Abou-Mohamed G, Franklin T, Caldwell RW, Caldwell RB (2003) Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol 162:1995-2004 (Pubitemid 36613056)
19. El-Remessy AB, Khalifa Y, Ola S, Liou G (2010) Diabetes-induced tyrosine nitration impairs glutamine synthetase activity: protective effects of cannabidiol. Mol Vis 16:1487-1495
20. 9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am J Pathol 163:1997-2008
21. Abdelsaid MA, Pillai BA, Matragoon S, Prakash R, Al-Shabrawey M, El-Remessy AB (2010) Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. J Pharmacol Exp Ther 332:125-134
22. Al-Gayyar MMH, Abdelsaid MA, Matragoon S, Pillai BA, El-Remessy AB (2010) Neuro and vascular protective effect of FeTPPs in NMDA-model: similarities to diabetes. Am J Pathol 177:1187-1197
23. Krishnamoorthy RR, Agarwal P, Prasanna G et al (2001) Characterization of a transformed rat retinal ganglion cell line. Brain Res Mol Brain Res 86:1-12 (Pubitemid 32124753)
24. Sarthy VP, Brodjian SJ, Dutt K, Kennedy BN, French RP, Crabb JW (1998) Establishment and characterization of a retinal Muller cell line. Investig Ophthalmol Vis Sci 39:212-216 (Pubitemid 28040483)
25. Lebrun-Julien F, Bertrand MJ, De Backer O et al (2010) ProNGF induces TNFalpha-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway. Proc Natl Acad Sci USA 107:3817-3822
26. El-Remessy AB, Al-Shabrawey M, Platt DH et al (2007) Peroxynitrite mediates VEGF's angiogenic signal and function via a nitration-independent mechanism in endothelial cells. FASEB J 21:2528-2539 (Pubitemid 47230682)
27. Carmignoto G, Comelli MC, Candeo P et al (1991) Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina. Exp Neurol 111:302-311
28. Suzuki A, Nomura S, Morii E, Fukuda Y, Kosaka J (1998) Localization of mRNAs for trkB isoforms and p75 in rat retinal ganglion cells. J Neurosci Res 54:27-37 (Pubitemid 28447186)
29. Coassin M, Lambiase A, Sposato V, Micera A, Bonini S, Aloe L (2008) Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma. Graefe's Archive for Clinical and Experimental Ophthalmology=Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 246:1743-1749
30. Ferruzzi MG, Lobo JK, Janle EM et al (2009) Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease. J Alzheimers Dis 18:113-124
31. Roghani M, Baluchnejadmojarad T (2009) Chronic epigallocatechingallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vasc Pharmacol 51:84-89
32. Yamabe N, Yokozawa T, Oya T, KimM(2006) Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J Pharmacol Exp Ther 319:228-236
33. Schroeder P, Klotz LO, Buchczyk DP, Sadik CD, Schewe T, Sies H (2001) Epicatechin selectively prevents nitration but not oxidation reactions of peroxynitrite. Biochem Biophys Res Commun 285:782-787 (Pubitemid 32924837)
34. Du Y, Smith MA, Miller CM, Kern TS (2002) Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem 80:771-779 (Pubitemid 34809229)
35. Harada T, Harada C, Nakayama N et al (2000) Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron 26:533-541
36. Srinivasan B, Roque CH, Hempstead BL, Al-Ubaidi MR, Roque RS (2004) Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J Biol Chem 279:41839-41845 (Pubitemid 39313632)
37. Madsen-Bouterse S, Mohammad G, Kowluru RA (2010) Glyceraldehyde-3- phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy. Investig Ophthalmol Vis Sci 51:1765-1772
38. Zou MH, Shi C, Cohen RA (2002) High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51:198-203 (Pubitemid 34517998)
39. Zhan X, Du Y, Crabb JS, Gu X, Kern TS, Crabb JW (2008) Targets of tyrosine nitration in diabetic rat retina. Mol Cell Proteomics 7:864-874 (Pubitemid 351737088)
40. Lee KF, Li E, Huber LJ et al (1992) Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69:737-749
41. Pehar M, Cassina P, Vargas MR et al (2004) Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis. J Neurochem 89:464-473 (Pubitemid 38495994)
42. Vargas MR, Pehar M, Cassina P, Estevez AG, Beckman JS, Barbeito L (2004) Stimulation of nerve growth factor expression in astrocytes by peroxynitrite. In Vivo 18:269-274 (Pubitemid 39069742)
43. Loeb DM, Maragos J, Martin-Zanca D, Chao MV, Parada LF, Greene LA (1991) The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell 66:961-966 (Pubitemid 121001729)
44. Rankin SL, Guy CS, Mearow KM (2005) TrkA NGF receptor plays a role in the modulation of p75NTR expression. Neurosci Lett 383:305-310 (Pubitemid 40805575)
45. Rankin SL, Guy CS, Rahimtula M, Mearow KM (2008) Neurotrophin-induced upregulation of p75NTR via a protein kinase C-delta-dependent mechanism. Brain Res 1217:10-24
46. Salis MB, Graiani G, Desortes E, Caldwell RB, Madeddu P, Emanueli C (2004) Nerve growth factor supplementation reverses the impairment, induced by type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabetologia 47:1055-1063 (Pubitemid 38918165)
47. Wiese S, Metzger F, Holtmann B, Sendtner M (1999) The role of p75NTR in modulating neurotrophin survival effects in developing motoneurons. Eur J Neurosci 11:1668-1676 (Pubitemid 29192242)
48. Kust BM, Brouwer N, Mantingh IJ, Boddeke HW, Copray JC (2003) Reduced p75NTR expression delays disease onset only in female mice of a transgenic model of familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord 4:100-105 (Pubitemid 36874779)
49. Turner BJ, Cheah IK, Macfarlane KJ et al (2003) Antisense peptide nucleic acid-mediated knockdown of the p75 neurotrophin receptor delays motor neuron disease in mutant SOD1 transgenic mice. J Neurochem 87:752-763 (Pubitemid 37310640)
50. Kitzman PH, Perrone TN, LeMaster AM, Davis BM, Albers KM (1998) Level of p75 receptor expression in sensory ganglia is modulated by NGF level in the target tissue. J Neurobiol 35:258-270 (Pubitemid 28246565)